Skip to main content
Equibles

Jeevan

Analyst

Oppenheimer

Equibles does not estimate personal net worth.

About Jeevan

Jeevan is recorded as Analyst at Oppenheimer. Jeevan has spoken on 1 earnings call across 1 company, most recently for Amneal Pharmaceuticals, Inc. on November 3, 2026. The companies whose calls Jeevan spoke on are classified in the Healthcare sector.

Jeevan on recent calls

“Could you clarify the revenue book for line near Tide and 3Q? And, you know, what are you seeing on early metrics from initial stocking versus patient demand? And then as a follow-up, I think the FDA only approved the 120-milligram syringe.”
Analyst — Oppenheimer, Amneal Pharmaceuticals Third Quarter 2026 Earnings Conference Call ·

Affiliation history

  • Oppenheimer

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity